CPAP devices for sleep apnoea therapy

If you experience sleep-disordered breathing, there’s probably a ResMed CPAP device that’s right for you.

All of our devices can be paired with a user-friendly coaching app to help you improve your experience and monitor your progress.

Your healthcare team can check your therapy data and offer tailored treatment solutions, either remotely or in person.

CPAP and APAP machines

Experience discreet, effective therapy for your sleep-disordered breathing with ResMed CPAP and AutoSet machines. These obstructive sleep apnoea therapy devices offer performance and comfort features.

AirSense 11 series
Designed to help you start right and stay right with PAP therapy

AirMini portable CPAP
The world’s smallest CPAP machine, designed for therapy on the go*

AirSense 10 Elite
Fixed-pressure therapy device

AirSense 10 AutoSet for Her
Auto-adjusting pressure therapy device for women

AirSense 10 AutoSet
Auto-adjusting pressure therapy device

Sleep bilevel machines

Our bilevel devices are ideal if you need positive airway pressure therapy but aren’t a suitable candidate for CPAP therapy. Designed with comfort in mind, a bilevel device from ResMed could offer you a good night’s sleep.

AirCurve 10 VAuto
Auto-adjusting bilevel therapy device

AirCurve 10 S
Fixed bilevel therapy device

Adaptive servo-ventilation**

AirCurve 10 CS PaceWave
Synchronised therapy for central sleep apnoea with and without obstructive sleep apnoea

Can’t find the product you’re looking for?

It might have been discontinued: please contact your ResMed sales representative for information. You can also visit our user guides and technical documents page to explore other resources.

Please refer to the user guide for relevant information related to any warnings and precautions to be considered before and during use of the product.

* As at 18 March 2021. 136 mm (W) x 84 mm (D) x 52 mm (H), 450 cm³.
** ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnoea.